This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Echelon Biosciences Incorporated. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Leena Chakravarty: Innovator in Lipid Assay Technology
Introduction
Leena Chakravarty is a prominent inventor based in Sandy, UT (US). She has made significant contributions to the field of lipid assay technology. Her innovative work focuses on the detection of lipids and associated enzymes, which has important implications in cancer screening.
Latest Patents
Leena holds a patent for an "Assaying apparatus, kit, and method for lipids and associated enzymes." This invention involves a lipid assay method, kit, and apparatus that exposes a protein with a lipid recognition motif to a solution containing a competing lipid. The method determines the presence of a target lipid, which has a stronger affinity to the lipid recognition motif than the competing lipid. The lipid recognition motif is preferably a pleckstrin homology (PH) domain, with the target lipid being a phosphoinositide. This assay can serve as a cancer screening method, where the detection of certain levels of a PI(3,4,5)P target lipid indicates the presence of cancer cells.
Career Highlights
Leena Chakravarty is associated with Echelon Biosciences Incorporated, where she continues to advance her research and development efforts. Her work has garnered attention for its potential applications in medical diagnostics and therapeutic interventions.
Collaborations
Leena collaborates with notable colleagues, including Beth E Drees and Glenn D Prestwich. These partnerships enhance her research capabilities and contribute to the innovative environment at Echelon Biosciences.
Conclusion
Leena Chakravarty's contributions to lipid assay technology exemplify her commitment to innovation in the field. Her patent and ongoing work have the potential to impact cancer detection and treatment significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile